Atlas Trials

A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women

Clinical trial NCT01101061 · COMPLETED

Trial details

NCT number
NCT01101061
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Osteopenia
Start date
2010-05-03
Primary completion
2010-11-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.